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ABSTRACT OF THESIS 
 
 
 
 
HYPOTHALAMIC MEDIATION OF ACUTE INCREASES IN ARTERIAL BLOOD 
PRESSURE AND RENAL SYMPATHETIC NERVE ACTIVITY DURING ELECTRICAL 
STIMULATION OF THE LAMINA TEMRINALIS 
 
Discrete electrical stimulation of the organum vasculosum of the lamina 
terminalis (OVLT) produces sympathetically-mediated increases in peripheral resistance 
and arterial blood pressure (ABP).  Since efferent fibers from the lamina terminalis 
innervate the kidney through polysynaptic connections, the present study determined 
whether electrical stimulation of the OVLT increased sympathetic outflow to the kidney.  
In anesthetized male, Sprague-Dawley rats (n=5) electrical stimulation of OVLT neurons 
produced frequency and current intensity dependent increases in renal sympathetic 
nerve activity (RSNA) and ABP that were abolished by ganglionic blockade with the 
nicotinic antagonist chlorisondamine (5mg/kg,i.v.).  Since neurons from the OVLT 
terminate within the hypothalamic paraventricular nucleus (PVH), the present study also 
determined whether these connections mediate a portion of sympathetic and pressor 
responses to electrical stimulation of the OVLT.  Bilateral inhibition of the PVH with the 
GABAA agonist muscimol (5mM/100nl) significantly attenuated the increase in ABP at all 
frequencies and current intensities.  Spike-triggered averaging of RSNA revealed that 
PVH inhibition significantly blunted the RSNA responses to OVLT stimulation at 100, 
200, but not 400µA. The present findings indicate that electrical stimulation of the OVLT 
increases RSNA and ABP and that these responses are partially mediated by the tonic 
activity of PVH neurons. 
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CHAPTER ONE 
OVERVIEW 
The sympathetic branch of the autonomic nervous system is essential in the 
control of blood pressure through vascular innervation in vertebrates.  Acute activation of 
the sympathetic nervous system evokes increases in blood pressure, mediated by 
increased vascular smooth muscle tone 1, 2.  Long-term elevation of sympathetic outflow 
to various vascular beds may contribute to the etiology and maintenance of chronic high 
blood pressure in the context of both human and experimental forms of hypertension 3, 4.   
A major controller of sympathetic outflow to the vasculature is a region of the 
forebrain known as the hypothalamus.  Hypothalamic efferent neurons project through 
mono- or polysynaptic pathways to preganglionic cell bodies in the spinal column.  These 
cell bodies give rise to axons, which terminate within the sympathetic chain ganglia.  
Post-ganglionic fibers innervate major vascular beds, including renal, hind-limb and 
mesenteric.  These neural connections provide a pathway by which stimulation of 
hypothalamic nuclei increases sympathetic nerve activity, total peripheral resistance and 
blood pressure 5-7.    
A significant portion of afferent signaling to the hypothalamus originates within 
the pre-optic area, immediately rostral to the hypothalamus.  The anterior portion of the 
third cerebral ventricle, known as the lamina terminalis, contains nuclei which lack a 
complete blood-brain barrier and are sensitive to changes in circulating angiotensin II and 
plasma osmolality 8-11.  Acute stimulation of these nuclei with either angiotensin II or 
hypertonic saline increases sympathetic nerve activity and blood pressure as well as the 
release of vasopressin from the neurohypophysis 12-14.  Furthermore, chronic stimulation 
of the lamina terminalis has been implicated in both renal and salt-sensitive hypertension 
15, 16.  The current data suggest that the connection between the lamina terminalis and the 
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hypothalamus is critical to acute and chronic sympathetically-mediated changes in blood 
pressure.     
  The primary goals of this study are: 1) to determine whether electrical 
stimulation of the lamina terminalis increases renal sympathetic nerve activity (RSNA) 
and arterial blood pressure (ABP) 2) to investigate hypothalamic mediation of 
sympathetic outflow to stimulation of the lamina terminalis and 3) to determine whether 
circulating vasopressin potentiates the pressor response to stimulation of the lamina 
terminalis.  The results of these experiments provide further insight into the mechanisms 
of neurally-mediated changes in blood pressure and contribute to a greater 
understanding of cardiovascular maladies, such as neurogenic hypertension.           
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CHAPTER TWO  
INTRODUCTION 
The lamina terminalis of the anteroventral wall of the third ventricle (AV3V) 
influences the release of vasopressin from the neurohypophysis and sympathetically-
mediated changes in blood pressure 12-14, 17, 18.   The circumventricular organs (CVO) of 
this region are exposed to plasma osmolality and hormone concentrations due to 
fenestrated capillaries, which dramatically increase the permeability of the blood-brain 
barrier (BBB).  Two of these CVO, the subfornical organ (SFO) and the organum 
vasculosum of the lamina terminalis (OVLT), sense changes in plasma sodium chloride 
and hormone concentrations through the presence of several possible types of receptors 
19, 20.  Through anatomical connections to both humoral and autonomic regions of 
hypothalamic nuclei, these structures influence the release of vasopressin and 
sympathetically-mediated changes in blood pressure, respectively 20-24.  The importance 
of these structures in the long-term regulation of blood pressure has been shown by their 
role in renal and salt-sensitive hypertension 13, 15, 16.  Thus, a greater understanding of the 
mono- and polysynaptic connections arising from the lamina terminalis and their role in 
the control of sympathetic outflow is essential to understanding blood pressure regulation 
and the development of neurogenic hypertension.  
 
A.  Neuroanatomy of the Lamina Terminalis 
Neuroanatomical research using various anterograde and retrograde tracing 
techniques has shown that the structures of the lamina terminalis, the SFO, OVLT and 
median preoptic nucleus (MnPO), all share substantial neuronal interconnections 19, 21, 25-
27.  Functionally, both excitatory and inhibitory neurons have been reported 19.  Possible 
neurotransmitters mediating these connections include: glutamate, serotonin, 
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acetylcholine, γ-amino butyric acid (GABA), angiotensin II (ANGII), neurotensin and 
neuropeptide Y 12, 19.   
The SFO and OVLT both possess receptors to circulating hormones found within 
the blood plasma.  In particular, densities of ANGII type-1 (AT1) receptors have been 
localized to both structures 11, 28, 29.  In vivo studies observing the expression of the proto-
oncogene c-fos showed increased protein expression within the SFO and OVLT to 
intravenous ANGII challenge 10.  By comparison, more SFO neurons demonstrated Fos 
expression than OVLT neurons to ANGII.  This finding suggests that sympathetic and 
pressor responses to ANGII or hypertonic saline may be primarily mediated by either 
nucleus 30, 31.  Furthermore, extracellular recording studies show an increase in the firing 
rate of SFO neurons to intracarotid ANGII infusion 32, 33.  Though ANGII sensitivity by 
these structures has been the focus of much investigation, examples of additional 
circulating hormones with receptors in the lamina terminalis include atrial natriuretic 
peptide, relaxin and somatostatin 19.   
The OVLT and SFO are also sensitive to changes in plasma sodium chloride, 
shown both by in vitro and in vivo experiments 8, 9, 32.  A recent study by Ciura and 
Bourque suggests that the transient receptor potential vanilloid 1 (TRPV1) is responsible 
for the osmosensitivity of OVLT neurons 20.  Cell recordings of isolated OVLT neurons in 
vitro showed that neuronal discharges to addition of hypertonic saline were absent from 
TRPV1 knockout mice compared to wild type controls 20.  Furthermore, excitation to 
hypertonic saline in wild type neurons could be blocked by addition of a TRPV antagonist 
20.  These findings suggest that sympathetic and pressor responses to hyperosmotic 
stimulation of the lamina terminalis with sodium chloride may be mediated by this 
receptor.  In all, the lamina terminalis is comprised of interconnected structures, which 
sense changes in plasma hormones and sodium chloride concentration through the 
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presence of receptors to these circulating substrates.  Furthermore, these receptors may 
mediate changes in SNA and ABP to hypertonic saline and ANGII stimulation.   
              
B.  Hypothalamic and Medullary Efferents        
In addition to interconnections within the lamina terminalis, the CVO send efferent 
projections to both magnocellular and parvocellular regions of the hypothalamus, 
including the supraoptic nucleus (SON) and the paraventricular hypothalamus (PVH) 17, 22, 
23.  Magnocellular neurons of the SON and PVH terminate within the neurohypophysis to 
release vasopressin upon activation with ANGII and hypertonic saline 34.  Parvocellular 
neurons project to brainstem and spinal nuclei, including the rostral ventrolateral portion 
of the medulla oblongata (RVLM) and intermediolateral cell column (IML), respectively 12, 
18, 35-37.  Neurons leaving the IML synapse within the sympathetic chain ganglia.  From this 
point, postganglionic fibers innervate major vascular beds, including the renal, hindlimb 
and mesenteric circulations.   
Recently, Sly et al. reported pseudorabies-positive cells within the lamina 
terminalis 4 days after injection of the virus into the renal cortices of anesthetized rats 5.  
Interestingly, viral progeny were localized to the PVH 1 day prior to infection of the lamina 
terminalis 5.  In similar experiments, microinjection of pseudorabies into the posterior 
pituitary revealed virus-positive cell bodies in the SON and PVH following 16 hours 
incubation 38.  Furthermore, infected neurons were located in the dorsal cap of the OVLT 
and on the peripheral edges of the SFO 20-28 hours following microinjection 38.  Support 
for these findings is provided by in vivo extracellular recording studies in which 
stimulation of the SFO and OVLT excited cell bodies within the PVH 39, 40.  The available 
data indicate polysynaptic neuronal connections from the lamina terminalis to peripheral 
sympathetic fibers.  Activation of these pathways with either ANGII or hypertonic saline 
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increases sympathetic outflow and blood pressure through increased peripheral 
resistance 30, 31.  These pathways are diagrammatically summarized in Figure 1.         
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Figure 1. Schematic of neural circuitry under investigation.  SFO, subfornical organ
MnPO, median preoptic nucleus AC, anterior commisure OVLT organum vasculosum of 
the lamina terminalis ox, optic chiasm 3V, third ventricle PVH, paraventricular 
hypothalamic nucleus PP, posterior pituitary AP, anterior pituitary RVLM, rostral 
ventrolateral medulla IML, intermediolateral cell column. 
 
 
 
 
 
 
 
 
 
 
 7
C.  Vasopressin Release 
In pioneering experiments conducted by Verney and Jewell in the 1940’s and 
50’s, infusion of hypertonic saline or sucrose, but not urea, increased vasopressin 
secretion from the neurohypophysis 41, 42.  Because urea readily equilibrates between the 
intra- and extracellular environment, it was an ineffective osmotic stimulus of vasopressin 
secretion.  This observation led Verney to conclude that the release of vasopressin was 
mediated by dehydration of neurons within the forebrain.     
In later studies involving electrolytic lesion of the AV3V, the lamina terminalis was 
suggested as the forebrain site responsible for vasopressin release after ANGII or 
hyperosmotic stimulation 14, 43.  Due to the magnitude of these lesions, information 
regarding the contribution of each nucleus to this response was limited.  Studies utilizing 
discrete lesion of the OVLT and SFO revealed that destruction of either organ attenuated 
the release of vasopressin in response to hyperosmotic stimulation or ANGII 34, 44, 45.  
However, ablation of both structures was necessary for elimination of vasopressin 
release to hypertonic saline 34, 46.  This finding suggests that both the SFO and OVLT are 
sufficiently osmosensitive to increase plasma vasopressin to an osmotic challenge.  
Indeed, this notion is supported by studies in which osmosensitivity was observed in 
neurons of both nuclei 8, 9, 32.  Altogether, these data present the lamina terminalis as the 
central forebrain site influencing vasopressin release from the neurohypophysis.   
Though circulating vasopressin is widely recognized for its role in renal tubular 
reabsorption of water, studies have also suggested its influence in acute pressor 
responses to lamina terminalis stimulation.  Mangiapane and Brody reported that 
increases in ABP after electrical stimulation of the SFO were augmented by circulating 
vasopressin 2.  Additionally, vasopressin (V1) receptors have been located in both the 
SFO and OVLT 47 and cell recording studies have observed excitation of SFO neurons to 
the hormone 48-50.  Taken together, these data suggest that circulating vasopressin 
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contributes to pressor responses evoked by stimulation of the lamina terminalis, possibly 
through action upon the SFO and OVLT.  A goal within the present study was to 
determine whether circulating vasopressin influences acute elevations in ABP to discrete 
electrical stimulation of the OVLT.   
 
D.  Dipsogenic responses 
Drinking behavior has been observed in response to a variety of stimuli, including 
hyperosmotic plasma, ANGII, hypovolemia and dehydration 19, 43, 51.  In the 1950’s, 
Andersson was the first to observe dipsogenesis to infusion of hypertonic saline in 
different regions of the goat hypothalamus 52.  Later studies conducted by Epstein et al. 
noted an increase in water intake to intracranial injection of ANGII 53.  Subsequent 
investigation showed that electrolytic lesion of the AV3V eliminated drinking responses to 
ANGII, hyperosmotic challenges, and dehydration 43.  Though these experiments support 
the lamina terminalis in mediation of water intake, limited information was provided on the 
contribution of each nucleus.   
In a series of experiments conducted by Thrasher et al., the OVLT was ablated 
prior to systemic administration of hypertonic saline or ANGII in dogs.  Infusion of either 
substance in lesioned animals failed to evoke normal dipsogenic responses 34, 45.  
Similarly, in studies performed by Simpson et al., selective ablation of the SFO blocked 
increases in water intake to systemic infusion of ANGII in the rat 54.  In contrast, McKinley 
and colleagues reported that lesion of either the OVLT or SFO did not decrease water 
intake to hypertonic saline infusion or water deprivation.  In these experiments, only 
lesions encompassing the majority of the lamina terminalis abolished acute water 
ingestion responses to intravenous hypertonic saline 55.  Similar to vasopressin secretion, 
appropriate dipsogenic responses to ANGII or hypertonic saline likely require the 
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participation of all lamina terminalis nuclei, though incomplete ablation may result in a 
residual increase in water intake.       
           
E. Lamina Terminalis and Sympathetically Mediated Cardiovascular Changes 
In addition to influencing vasopressin release and dipsogenic behaviors, the 
structures of the lamina terminalis mediate changes in ABP through excitation of the 
sympathetic nervous system.  Mangiapane and Brody were the first to demonstrate that 
electrical stimulation of either the SFO or OVLT increases ABP through increased 
vascular resistance.  Moreover, blood pressure elevation and hemodynamic effects were 
the result of sympathetic activation, as intravenous infusion of a ganglionic blocking agent 
abolished these responses 1, 2.   
In the context of hyperosmotic stimulation, human and animal studies have 
reported elevations in sympathetic nerve activity to acute increases in plasma osmolality 
12, 56.  Chen and Toney showed that acute intracarotid infusion of hypertonic saline 
evoked significant increases in both RSNA and ABP 31.  Furthermore, these responses 
were attenuated following blockade of AT1 receptors within the PVH 31.  These data are 
supported by experiments in which chemical inhibition with a GABAA agonist or blockade 
of glutamate receptors within the PVH blunted increases in lumbar SNA (LSNA) to 
hypertonic saline 57.  In this same preparation, knife cuts separating the CVO from the 
hypothalamus abolished lumbar sympathoexcitation to hypertonic saline 57.  Taken 
together, the data suggest that the forebrain CVO are integral to changes in SNA and 
ABP to hypertonic saline.  Moreover, a portion of these responses are mediated by 
synaptic transmission in the PVH.      
In contrast to hypertonic saline, ANGII has shown inconsistent affects upon SNA.  
In one study, plasma norepinephrine concentration either decreased or remained 
unchanged to chronic intravenous ANGII infusion in conscious dogs 58.  In a conflicting 
 10
study, chemical sympathectomy prevented increased systolic blood pressure to chronic 
subcutaneous infusion of ANGII 59.  Furthermore, structural changes in arterial walls to 
ANGII infusion observed in control animals were not apparent in sympathectomized rats 
59.  One possible explanation for these findings, as suggested by Osborn et al. 13, could 
be the involvement of the baroreflex.  Because the baroreflex may exert an inhibitory 
influence upon the sympathetic nervous system to systemic infusion of ANGII 60, 
interruption of the baroreflex circuit would likely lead to consistent ANGII-mediated 
sympathoexcitation.  Indeed, intravenous infusion of ANGII following chronic sino-aortic 
denervation increases both ABP and LSNA in unanesthetized rats 30.   
In summary, the CVO of the lamina terminalis mediate increases in sympathetic 
outflow and ABP to changes in plasma sodium concentration and ANGII.  However, two 
questions remain: 1) whether discrete stimulation of individual lamina terminalis nuclei 
evokes quantifiable increases in SNA and 2) whether these excitatory signals are relayed 
through the PVH.   In the present set of experiments, these questions will be tested 
through application of electrical current to the OVLT and recording of RSNA and ABP.  
The results will provide further insight into the efferent connections of the lamina 
terminalis and its role in acute changes in SNA and ABP.   
 
F. Lamina Terminalis and Hypertension    
Long-term elevations in sympathetic nerve activity have been observed in both 
human and experimental forms of hypertension 3, 4.  Because of its influence on 
sympathetic outflow and ABP, the lamina terminalis has been investigated as a potential 
mediator of neurogenic hypertension 13, 15, 18.  Though acute changes in SNA and ABP 
are attributed to activation of forebrain CVO, the question remains whether the lamina 
terminalis is involved in the development and maintenance of elevated blood pressure. 
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Previous studies have connected the lamina terminalis to both Grollman renal 
wrap and Goldblatt renal arterial coarctation hypertension 15, 61, 62.  In both forms, 
activation of the renin-angiotensin system plays a key role in the genesis of chronically 
elevated blood pressure.  In one study, electrolytic lesion of the AV3V prior to induction of 
two-kidney, one-clip Goldblatt hypertension diminished acute pressor responses and 
prevented the maintenance of elevated blood pressure 15.  Furthermore, lesion of the 
AV3V prior to or 6 weeks following one-kidney renal wrapping failed to produce or 
normalize the high blood pressure, respectively 61, 62.  Though the peripheral vasopressor 
effects of ANGII may also play a role, these data suggest that a significant portion of the 
chronically elevated blood pressure in Grollman or Goldblatt hypertension is supported by 
the action of ANGII upon the lamina terminalis.   
  More recently, studies have investigated a role for the lamina terminalis in salt-
sensitive hypertension 16, 63, 64.  The observation of decreased ABP to intracarotid infusion 
of hypotonic saline was first reported by Scherrer in 1963 65.   Similar studies performed 
by Schad and Seller showed that dilution of intracranial osmolality reduced RSNA in 
baroreceptor denervated cats 66.  In support of these findings, O’Donaughy and Brooks 
suggested that elevated plasma sodium acts upon forebrain circumventricular nuclei to 
increase sympathetic outflow in salt-sensitive hypertension 16, 64.  In these experiments, a 
deoxycorticosterone-salt (DOCA) pellet was implanted following unilateral nephrectomy.  
Drinking water was replaced with saline (1% NaCl and 0.2% KCl) ad libitum and blood 
pressure increased by ± 50mmHg in DOCA-salt but not control animals 16.  On the day of 
experiments, hypotonic saline was infused through the carotid artery and evoked 
depressor responses in hypertensive DOCA-salt animals, but not sham-operated, rats.  
Though the development of hypertension supported by chronically elevated SNA 
remains a source of ongoing research, the available data suggest that repeated 
stimulation of the OVLT and SFO by elevated ANGII and plasma sodium chloride may 
 12
play a critical role in the development of the hypertension 15, 16, 61, 62.  In this model, long-
term excitation of lamina terminalis nuclei by elevated plasma ANGII or sodium chloride 
influences sustained elevation in sympathetic outflow to major vascular beds.  Prolonged 
increases in total peripheral resistance lead to the onset of hypertension.  Despite the 
possible involvement of additional factors, such as plasma volume expansion and the 
direct vasoactive effects of ANGII 67, the available data indicate significant influences by 
the sympathetic nervous system in these forms of hypertension.      
 
G.  Summary and Rationale for Proposed Work 
  The past 50 years have produced a significant body of research implicating 
the lamina terminalis in fluid and electrolyte balance and blood pressure regulation.  Its 
receptors and position external to the blood brain barrier enables the brain to monitor 
plasma osmolality and circulating humoral factors, such as ANGII.  Transduction of these 
chemical and hormonal signals by the CVO activates downstream hypothalamic 
pathways, leading to the release of vasopressin and changes in sympathetic outflow and 
ABP 13, 14. 
  Despite these findings, information regarding the contribution of individual 
forebrain CVO to acute changes in SNA and ABP remains limited.  Mangiapane and 
Brody were the first to document pressor and hemodynamic responses to electrical 
activation of the lamina terminalis structures 1, 2.  Other Investigators demonstrated the 
involvement of the sympathetic nervous system in these responses through intravenous 
ganglionic blockade.  However, the behavior of post-ganglionic sympathetic fibers to 
activation of individual lamina terminalis nuclei remains unclear.  Therefore, one goal of 
the present study is to quantify activation of RSNA in support of acute pressor responses 
to direct electrical stimulation of the OVLT.  
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  Circulating vasopressin may augment the pressor responses observed to 
electrical stimulation of the CVO.  Since systemic application of an antagonist to 
vasopressin receptors decreased pressor responses to electrical stimulation of the SFO 2, 
a portion of the acutely elevated blood pressure could be attributable to vasopressin 
release that in turn increases peripheral resistance.  Thus, a second goal of the present 
study is to assess the role of circulating vasopressin in acute sympathetic and pressor 
responses to electrical stimulation of the OVLT through systemic administration of an 
antagonist to vasopressin receptors.          
Anatomical and functional studies have presented the PVH as a major 
downstream target of the lamina terminalis 5, 31, 57.  Blockade of AT1 and glutamate 
receptors within the PVH decreased RSNA and LSNA activation to intracarotid hypertonic 
saline 31, 57.  Because osmosensitivity has been observed in the SFO and OVLT 8, 9, 32, 
excitation of RSNA may represent the contribution of both nuclei.  Thus, one question 
that remains is whether the PVH mediates excitation of renal sympathetic outflow after 
discrete OVLT stimulation.  A third goal of the present study is to test this hypothesis 
through electrical stimulation of the OVLT while recording RSNA and ABP prior to and 
following chemical inhibition of the PVH.   
In conclusion, the lamina terminalis mediates acute SNA and ABP responses to 
changes in plasma osmolality and ANGII 30, 31  Furthermore, a role for the lamina 
terminalis in renal and salt-sensitive hypertension has been shown by several studies 15, 
16, 61.  These findings suggest that this region of the forebrain may be influential to the 
development and maintenance of chronic hypertension.  Future studies investigating 
etiological factors, such as behavioral and structural changes in these neuronal 
populations, are needed to fully evaluate this possible role.  Taken together, the findings 
of the present study represent foundational research into the regulation of the 
sympathetic nervous system and ABP by the lamina terminalis.      
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CHAPTER THREE 
 METHODS 
Animals: Male Sprague-Dawley rats (300-400 g, Charles River Laboratories) were 
housed in a temperature controlled facility (22-23 °C) with a 14:10h light-dark cycle (lights 
on at 7 am).  Animals were provided with tap water and standard laboratory rat chow ad 
libitum.  Experiments were performed in accordance with guidelines set by the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved 
by the University of Kentucky Institutional Animal Care and Use Committee. 
 
General Methods: On the day of experiments, rats were anesthetized with isoflurane (2-
3% in 100% O2) and instrumented with femoral arterial and venous catheters to measure 
arterial blood pressure and infusion of a paralytic agent (gallamine triethiode: 25 mg/kg 
per hour at 25 µL/h in 5% dextrose, Sigma Aldrich), respectively.  An additional catheter 
was placed in the jugular vein for administration of intravenous anesthesia (750 mg/kg 
urethane and 75 mg/kg α-chloralose).  A retroperitoneal incision was made to record 
RSNA using stainless steel electrodes, as described previously 68.  After tracheal 
cannulation, rats were paralyzed and artificially ventilated with oxygen-enriched room air.  
End-tidal PCO2 was maintained between 4.0-5.0% by adjusting ventilation rate (70-100 
breaths/min) or tidal volume (2-3 ml).  Body temperature was maintained at 37±1ºC using 
a heating pad.   
 
OVLT Stimulation and PVH Inhibition: Animals were placed into a stereotaxic head 
frame with the incisor bar positioned 3 mm below the interaural line.  After a small 
craniotomy, a stimulating electrode was angled 8° from the midsagittal plane and lowered 
into the OVLT at the following coordinates with reference to bregma and the dorsal 
surface of the brain: 1.0 mm lateral, 0-1.2 mm rostral, and 7.6-8.0 mm ventral.  Initially, 
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the OVLT was located by a pressor response to electrical stimulation of 50 Hz at 200 µA.  
Once baseline variables stabilized for 30 min, electrical stimulation was applied to the 
OVLT at various frequencies (10, 50 and 100 Hz) and intensities (100, 200 and 400 µA) 
for 5 seconds.  At the conclusion of each experiment, sites were marked by a small lesion 
produced by DC current at 50 µA for 10 sec. 
In experiments investigating the role of the PVH in OVLT stimulation, a second 
glass micropipette filled with the GABAA receptor agonist muscimol (5 mM 100nl in aCSF) 
was lowered into the PVH at the following coordinates in reference to bregma: 1.8 mm 
caudal to bregma, 0.5-0.7 mm lateral to midline, and 7.6-7.8 mm ventral to the dorsal 
surface of the cortex.  Drugs were bilaterally injected into the PVH using a pneumatic 
picopump. 
In order to quantify the magnitude of the sympathetic responses to electrical 
stimulation, single pulses (1.0 ms duration, 1 Hz) were applied to the OVLT for 60 sec.  
Spike-triggered averages of RSNA were generated from 60 sweeps at 3 different 
stimulation intensities (100, 200, and 400 µA).  OVLT stimulation at these parameters 
was conducted both before and after ganglionic blockade with the nicotinic antagonist 
chlorisondamine (5 mg/kg, i.v.). 
 
Experimental Design: To determine whether activation of the sympathetic nervous 
system is responsible for pressor responses to electrical stimulation of the OVLT, 
synaptic transmission at the sympathetic chain ganglia was blocked with chlorisondamine 
(5 mg/kg, i.v.).  In a second group of animals, the PVH was bilaterally inhibited with the 
GABAA receptor agonist muscimol.  Similarly, electrical stimulation of brain regions 
peripheral to the OVLT were made in order to control for any cardiovascular changes due 
to fibers of passage through the OVLT.  In animals receiving control microinjections of 
aCSF bilaterally into the PVH, experiments were conducted in vasopressin-blocked 
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animals (Manning compound [d(CH2)5Tyr2(ME)Arg8]-vasopressin, 10 µg/kg/ml, i.v.) 69.  
Microinjections of either muscimol or aCSF into the PVH contained rhodamine beads for 
later histological verification of injection sites.  Baroreflex function was also assessed with 
sodium nitroprusside (10 µg/kg in 100 µl, i.v.) before and after intravenous administration 
of Manning compound (Table 1).   
 
Histology: At the conclusion of experiments, rats were euthanized with a lethal injection 
of saturated KCl and were perfused transcardially with 50 ml of 4% paraformaldehyde in 
0.1 M phosphate-buffered saline.  Brains were removed, post-fixed overnight in 4% 
paraformaldehyde at 4 ºC, and transferred to 30% sucrose for 2-3 days.  Forebrains were 
sectioned at 50 µm on a vibratome, sections were mounted on glass slides, and counter 
stained with cresyl violet.  PVH injection sites were confirmed by the localization of 
rhodamine beads. 
  
Data Analysis: In order to quantify changes in blood pressure, 30 seconds of baseline 
activity was recorded prior to electrical stimulation and compared to a 1 second peak in 
ABP.  Similarly, changes in RSNA were evaluated by spike-triggered averaging and 100 
ms of baseline activity was compared to a 10 ms peak response.  Figures 2, 3 and 8 
were analyzed by 2 way ANOVA with F ratios.  Mean differences were determined using 
the least significant range of the student Newman-Keuls evaluation (P<0.05).  Figures 4 
and 5 were analyzed by paired t-test (P<0.05).     
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CHAPTER FOUR 
RESULTS 
OVLT Stimulation Before and After Ganglionic Blockade: Electrical stimulation of the 
OVLT at various frequencies (10, 50, 100 Hz) and current intensities (100, 200, 400 µA) 
evoked frequency-current intensity dependent pressor and RSNA responses (Figures 2 
and 3).  Following intravenous administration of the ganglionic blocker, chlorisondamine 
(5 mg/kg, i.v.), pressor and RSNA responses evoked by electrical stimulation of the OVLT 
were abolished (Figures 2 and 3; p<0.05).  OVLT stimulation sites were defined 
functionally by pressor responses to a brief pulse train (50 Hz, 1 ms pulse duration, 3 s, 
100-400 µA).  Figure 2A depicts raw traces of ABP before and after electrical stimulation 
of the OVLT at various frequencies and current intensities.  At each frequency, black 
upper traces indicate baseline ABP stimulation before and grey traces following 
ganglionic blockade.  Mean ABP responses are summarized in part B of Figure 2 (n=5).  
Similarly, Figure 3A illustrates spike-triggered averaging of an example of RSNA 
responses to electrical stimulation of the OVLT.  Black traces indicate baseline, whereas 
grey traces indicate stimulation following ganglionic blockade.  Group RSNA data are 
summarized in part B (n=5).  Following ganglionic blockade, electrical stimulation failed to 
evoke a change in either ABP or RSNA.       
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Figure 3. Spike-triggered averaging of RSNA (A) before (black) and after (grey) infusion 
of the ganglionic blocker, chlorisondamine (5 mg/kg, i.v.).  Group data are summarized in 
(B) (n=5).  Group data were analyzed by 2-way ANOVA with F ratios.  Mean differences 
were determined using the least significant range of the student Newman-Keuls
evaluation (P<0.05).
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PVH Inhibition Experiments: Bilateral inhibition of the PVH with the GABAA agonist 
muscimol (5 mM, 100 nl) significantly attenuated the pressor (n=6) and RSNA (n=4) 
responses to electrical stimulation of the OVLT at nearly all frequencies and current 
intensities (p<0.05) (Figures 4 and 5).  The exception to this finding is the RSNA data 
from the greatest magnitude of electrical stimulation (400 µA), which was not significantly 
decreased following muscimol microinjection.  However, ABP responses from this current 
intensity were significantly reduced following muscimol treatment.  Figure 4A shows raw 
traces of ABP to electrical stimulation of the OVLT.  At each frequency, black upper 
traces indicate baseline ABP stimulation prior to muscimol microinjection and grey traces 
indicate ABP following drug treatment.  Mean ABP responses are summarized in part B 
of Figure 4 (n=6).  Similarly, Figure 5A illustrates spike-triggered averaging of an example 
of RSNA responses to electrical stimulation before and after muscimol microinjection.  
Black traces indicate baseline, whereas grey traces indicate OVLT stimulation following 
drug treatment.  Group RSNA data are summarized in part B (n=4).  With the exception of 
400 µA, PVH muscimol significantly reduced RSNA responses to electrical stimulation of 
the OVLT (p<0.05).   
 
Control Experiments: Electrical stimulation of the OVLT increased ABP and RSNA 
similarly in rats prior to and post microinjection of aCSF into the PVH (Figures 6 and 7).  
Prior to bilateral microinjection of aCSF (100 nl) into the PVH, animals were pretreated 
with the V1 receptor antagonist, Manning compound (10 µg/kg/ml, i.v.).  Figure 6A shows 
example traces of pressor responses evoked by electrical stimulation of OVLT.  At each 
frequency, black upper traces indicate baseline responses prior to bilateral aCSF 
microinjection and grey traces indicate changes in ABP to electrical stimulation following 
microinjection.  Mean ABP responses are summarized in part B of Figure 6 (n=3).  
Similarly, Figure 7A illustrates spike-triggered averaging of an example of RSNA 
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responses to electrical stimulation before and after aCSF microinjection.  Black traces 
indicate baseline, whereas grey traces indicate stimulation following control 
microinjection.  Group RSNA data are summarized in part B (n=3).  At each current 
intensity, ABP and RSNA increased similarly before and after microinjection of aCSF into 
the PVH of all three Manning Compound pretreated rats. 
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Figure 5. Spike-triggered averaging of RSNA (A) before (black) and after (grey) bilateral 
microinjection of the GABAA agonist, muscimol (5 mM, 100 nl) into the PVH.  Group data 
summarized in (B) (n=4).  Significant differences were evaluated by paired t-test (P<0.05).
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Figure 6. ABP responses to electrical stimulation of the OVLT (A) before (black) and after 
(grey) bilateral microinjection of artificial CSF (100 nl) into the PVH with Manning 
Compound pretreatment (10 µg/kg/ml, i.v.).  Group data are summarized in (B) (n=3).  At 
each current intensity, ABP increased similarly before and after aCSF in all 3 rats tested. 
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Figure 7. Spike-triggered averaging of RSNA (A) before (black) and after (grey) bilateral 
microinjection of aCSF (100 nl) into the PVH with Manning Compound pretreatment (10 
µg/kg/ml, i.v.).  Group data are summarized in (B) (n=3).  At each current intensity, RSNA 
increased similarly before and after aCSF in all 3 rats tested.   
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Manning Compound: Manning compound, a vasopressin type-1 antagonist, (10 
µg/kg/ml, i.v.) was administered to 5 animals and ABP and RSNA responses were 
compared between pre- and post-treatment.  Pressor and sympathetic responses to 
electrical stimulation of the OVLT were not significantly different following infusion of 
Manning compound (Figure 8; p<0.05). Figure 8A shows summary graphs of pressor 
responses evoked by electrical stimulation, black and grey bars indicating pre- and post-
administration of drug, respectively.  Changes in RSNA to electrical stimulation before 
and after Manning compound treatment are summarized in Figure 8B (n=5).  Prior 
treatment with Manning compound did not affect the pressor or sympathetic responses to 
electrical stimulation of the OVLT (p<0.05). 
 
Sodium Nitroprusside: Sodium nitroprusside, a vascular smooth muscle vasodilator (10 
µg/kg, i.v.), was administered to animals prior to intravenous infusion of Manning 
compound (10 µg/kg/ml).  Depressor responses evoked by nitroprusside administration 
were not significantly different following infusion of Manning compound (Table 1A; 
p<0.05).  Similarly, increases in RSNA evoked by nitroprusside infusion were not 
significantly altered following infusion of Manning compound (Table 1B; p<0.05).    
 
Histological Analysis: Electrical stimulation sites within the OVLT and microinjection 
sites within the PVH were verified histologically.  Figure 9 indicates anatomical levels of 
the OVLT.  Marked sites indicate the tip of the stimulating electrode verified by 
visualization of OVLT lesion with bright-field microscopy.  Figure 10 indicates anatomical 
levels of the PVH.  Microinjection sites were verified histologically via fluorescent 
microscopy.   
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Figure 8. Summary data of change in MAP and RSNA to OVLT electrical stimulation 
before (black) and after (grey) infusion of Manning Compound (AVPx, 10 µg/kg/ml, i.v., 
n=5).  Groups were analyzed by 2-way ANOVA with F ratios.  Mean differences were 
determined using the least significant range of the student Newman-Keuls evaluation 
(P<0.05). 
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Table 1. ABP (A) and RSNA (B) responses to sodium nitroprusside (10 µg/kg, i.v.) 
administration prior to and post infusion of Manning Compound (10 µg/kg/ml, i.v.).   ABP 
is expressed as MAP in units of mmHg and RSNA is expressed in millivolts (mV).  
Changes in RSNA are also expressed as a percent of baseline.  Values are ± SE.  
*Significant difference from baseline (P<0.05).     
 
 
A    
Pre Manning Compound (n=7)  
Baseline (30s) Peak (1s) Absolute Change  
115.8±3 86.9±4 -28.9±4  
    
Post Manning Compound (n=5)  
Baseline (30s) Peak (1s) Absolute Change  
118.8±5 86.7±6 -32.1±4  
    
B    
Pre Manning Compound (n=7) 
Baseline (30s) Peak (1s) Absolute Change % Baseline 
0.151±0.015 0.256±0.027 0.105±0.017 173±12 
    
Post Manning Compound (n=5) 
Baseline (30s) Peak (1s) Absolute Change % Baseline 
0.191±0.013 0.33±0.025 0.139±0.014 172.6±6 
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Figure 9. Anatomical levels of the OVLT with stimulation sites indicated.  DBB diagonal 
band of Brocha, AC anterior commisure, LV lateral ventricle, 3V third ventricle, OX optic 
chiasm.
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Figure 10. Anatomical levels of the PVH with microinjection sites indicated. 3V third 
ventricle, AH anterior hypothalamus, PVH (parvo) parvocellular region of the PVH, PVH 
(magno) magnocellular region of the PVH, f fornix.
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CHAPTER FIVE 
DISCUSSION 
The present study investigated the control of RSNA and ABP by the lamina 
terminalis and the neural pathways connecting this region to the hypothalamus.  To 
accomplish this, the OVLT was electrically stimulated while RSNA and blood pressure 
responses were recorded in anesthetized, Sprague-Dawley rats in the absence and 
presence of ganglionic blockade and pharmacologic inhibition of the PVH.  The major 
findings in this study were: 1) electrical stimulation of the OVLT evoked increases in 
RSNA and ABP, which were abolished by ganglionic blockade 2) bilateral inhibition of the 
PVH blunted pressor responses to OVLT electrical stimulation and 3) systemic 
administration of a vasopressin antagonist prior to OVLT stimulation did not affect 
sympathomimetic and/or pressor responses.  Taken together, the data suggest that 
electrical activation of the OVLT increases RSNA and ABP through connections with the 
PVH and independent of vasopressin acting upon systemic receptors.    
Electrical stimulation of the OVLT increased RSNA and ABP in a frequency and 
current intensity dependent fashion.  Pressor responses were a direct result of increased 
postganglionic sympathetic outflow, since ganglionic blockade with chlorisondamine 
abolished both the increases in RSNA and blood pressure at all levels of OVLT 
stimulation (Figure 2).  To verify that increased RSNA and ABP resulted from OVLT 
activation, control experiments stimulated sites immediately juxtaposed to this nucleus.  
Passage of test currents (50 Hz, 200 µA) into the rostral-caudal, medial-lateral and 
dorsal-ventral planes exterior to the OVLT, evoked either a sub-maximal increase or no 
change in ABP.   Pressor responses were observed 1.2 mm rostral of bregma in the 
plane of OVLT, and these responses reached a maximum between 0.5 and 0.7 mm 
rostral of bregma.  These coordinates corresponded with the known location of the OVLT 
70.  At the conclusion of all experiments, the OVLT was electrolytically lesioned for 
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histological verification of electrode placement at all stimulation sites.  Analysis of brain 
sections for electrolytic lesions verified successful electrode placement within the 
boundaries of the OVLT (Figure 9).  Altogether, the results support the hypothesis that 
activation of the OVLT is responsible for increases in RSNA and ABP.  
Previous experiments attempted to determine a role for the lamina terminalis in 
blood pressure regulation through electrical stimulation of the anteroventral wall of the 
third ventricle (AV3V) 71, 72.  In anesthetized Sprague-Dawley rats, electrical stimulation 
within the AV3V resulted in depressor responses, increases in hindquarter blood flow, 
and decreases in both mesenteric and renal blood flow 71, 72.  Two possible explanations 
for these results include: 1) spread of current from the stimulation site and 2) position of 
the stimulating electrode.  Due to the magnitude of electrical current (~1.5 mA), multiple 
nuclei may have been activated within the lamina terminalis.  Subsequent reports would 
reveal that stimulation of the OVLT and SFO increases ABP and depressor responses 
were only evoked by stimulation of the MnPO 1, 2.  However, decreases in mesenteric and 
renal blood flow were noted to stimulation of either the OVLT or SFO 1, 2.  Thus, the 
depressor and hemodynamic responses to stimulation of the AV3V may represent the 
contribution of multiple, functionally distinct nuclei.   
The second caveat of these experiments is the position of the stimulating 
electrode.  Given the placement of the electrode tip within the third ventricle, the cerebral 
spinal fluid may conduct current to periventricular tissue adjacent to the AV3V.  In doing 
so, current may activate other nuclei or fibers of passage also influencing blood pressure.  
Thus, attributing changes in blood pressure to activation of AV3V nuclei alone is difficult.  
Altogether, these findings represent early attempts to characterize blood pressure 
regulation by the structures of the AV3V. 
Later studies utilizing discrete electrical stimulation of the lamina terminalis were 
the first to describe roles for the individual nuclei in hemodynamic and blood pressure 
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changes.  In anesthetized Sprague-Dawley rats, electrical stimulation (constant current, 
200 µA) of the SFO and OVLT increased ABP, whereas the median preoptic nucleus 
(MnPO) produced either a slight depressor response or no change in ABP  1, 2.  
Interestingly, the hemodynamic responses to stimulation of the SFO and OVLT were not 
identical.  SFO stimulation increased resistance in the mesenteric, hindquarter and renal 
vascular beds, whereas OVLT stimulation only increased resistance to the mesenteric 
and renal circulations 1, 2.  This finding suggests that activation of either nucleus may 
influence sympathetic outflow to specific vascular beds.  In all cases, changes in vascular 
resistance and ABP were prevented following ganglionic blockade with intravenous 
chlorisondamine.  These findings were the first to show that electrical stimulation of the 
OVLT or SFO produces sympathetically-mediated changes in peripheral hemodynamics.  
The data from the present study affirm and extend these reports, indicating for the first 
time that activation of the OVLT increases sympathetic outflow to the renal vasculature 
and these sympathomimetic responses are associated with increased ABP. 
To determine whether circulating vasopressin affected the magnitude of pressor 
responses to electrical stimulation of the OVLT, the vasopressin receptor type 1 
antagonist Manning compound (10 µg/kg/ml i.v.) was administered following OVLT 
stimulation.  Subsequent electrical stimulation of the OVLT showed that blockade of 
systemic vasopressin receptors had no affect upon RSNA or ABP responses (Figure 8).  
The dosage of Manning compound was similar to previous studies and was shown to 
prevent pressor responses to intravenous administration of vasopressin (20 ng) 16, 64, 69.  
These findings are consistent with the results of a recent report in which RSNA and ABP 
responses to intracarotid infusion of hypertonic saline were not different before and after 
intravenous administration of Manning compound 69.  These results suggest that 
circulating vasopressin does not augment sympathetic and pressor responses to acute 
electrical or chemical stimulation of the lamina terminalis.    
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However, conflicting results from another study suggest that pressor responses to 
electrical stimulation of the SFO were attenuated following intravenous administration of a 
vasopressin antagonist 2.  One explanation for this discrepancy is the duration of 
stimulation.  In the present study, electrical current was passed through the OVLT for 5 
seconds at various frequencies and current intensities (see methods).  In similar studies 
by Mangiapane and Brody, the SFO was stimulated for 60 seconds at a frequency of 32 
Hz and 200 µA 2.  Thus, the duration of applied current in these experiments may have 
increased circulating vasopressin to a greater concentration than the present study.  To 
this end, circulating vasopressin augmented pressor responses observed in these 
reports.     
Prior studies describing vasopressin receptors within the SFO and OVLT suggest 
the presence of a central mechanism whereby circulating vasopressin may directly affect 
sympathetically mediated changes in blood pressure 47, 49, 50.  To test this hypothesis, 
Smith and Ferguson microinjected vasopressin (5 pmol in 0.5 µl) into the SFO of 
urethane anesthetized rats.  Vasopressin decreased blood pressure and this depressor 
response was abolished by intravenous infusion of a vasopressin antagonist 73.  Though 
this finding suggests that circulating vasopressin might act upon the lamina terminalis, it 
may not contribute to sympathetically-mediated blood pressure elevation.  
The second major finding of the present study is that the PVH mediates pressor 
and RSNA responses to OVLT electrical stimulation.  Bilateral microinjection of the 
GABAA agonist muscimol (100 nl) into the PVH significantly blunted pressor responses to 
electrical stimulation of the OVLT at all frequencies and current intensities (Figure 4).  
Similarly, renal sympathetic responses were blunted following muscimol treatment at all 
stimuli with the exception of 400 µA.  Dosages of muscimol (0.5 nmoles) were within the 
effective range for PVH inhibition (0.05-1.5 nmoles), as described previously  68, 74-76.  
Microinjection sites within the PVH were verified by the presence of fluorescent 
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rhodamine beads at the injection sites.  In control groups, microinjections of similar 
volumes of aCSF into the PVH evoked no change in RSNA and ABP (Figure 6).  Taken 
together, these results suggest that the PVH significantly influences sympathetic and 
pressor responses to electrical stimulation of the OVLT. 
This connection between the lamina terminalis and the PVH in the context of 
sympathetic nerve activity and ABP is supported by both anatomical and functional 
studies.  Anatomical data have shown that the PVH receives dense axonal projection 
from nuclei within the lamina terminalis 21, 25, 77.  In a recent study, positive cell bodies 
were observed within the lamina terminalis following injection of the transneuronal 
retrograde label pseudorabies virus into the renal cortex of a rat.  Infection of the PVH 
was noted prior to the lamina terminalis, suggesting a common neuronal pathway 5.  
Functionally, activation of the PVH with either chemical or electrical stimulation has been 
shown to evoke increases in sympathetic outflow and ABP 6, 7.  Studies utilizing knife cuts 
caudal to the lamina terminalis eliminate changes in lumbar SNA to hypertonic saline and 
attenuate ABP to intravenous ANGII, respectively 57, 78.  Furthermore, chemical blockade 
of either AT1 or glutamate receptors within the PVH decreases RSNA or LSNA 
responses to hypertonic saline, respectively 31, 57.  In concert with the present findings, the 
available data support a role for the PVH in the mediation of sympathetic signaling from 
the lamina terminalis.  
Interestingly, the present study shows that the level of RSNA and ABP inhibition 
decreases with increasing frequency and current stimulation of the OVLT.  Several 
alternative explanations may account for this outcome: 1) muscimol was not an effective 
inhibitor of neurotransmission in the PVH 2) some neurons from the lamina terminalis do 
not synapse within the PVH 3) electrical current overwhelmed chemical inhibition of the 
PVH, evoking a residual increase in RSNA and ABP and 4) alternative pathways exist 
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that also support changes in sympathetic outflow and ABP to stimulation of the lamina 
terminalis.   
The neurotransmitter γ-aminobutryic acid (GABA) is an inhibitory neuropeptide 
that hyperpolarizes cell bodies through induction of an inward chloride current.  Muscimol 
mimics the inhibitory action of GABA through selective binding to the endogenous 
ionotropic GABAA receptor on the cell body 79, 80.  In an in vitro study of rat hippocampal 
neurons, Segal and Barker reported channel opening durations of 22.9 ms and 38.8 ms 
for GABA and muscimol, respectively 81.  Functional studies show that bilateral 
microinjection of muscimol (0.05-1.5 nmol) into the PVH decreases sympathetic nerve 
activity and ABP in anesthetized rats for a period of at least 120 minutes 74-76.  Altogether, 
these data support the notion that muscimol effectively inhibits neural transmission in the 
PVH. 
Reduced inhibition of SNA and ABP responses to OVLT stimulation may also 
suggest the presence of fibers of passage.  These axons may pass directly from the 
lamina terminalis to brainstem or spinal targets without synapsing in the PVH.  Because 
muscimol inhibits neurons though GABAA receptors on cell bodies, these fibers of 
passage would be unaffected.  Therefore, RSNA and ABP responses following chemical 
inhibition of the PVH at higher frequencies and current intensities could be attributable to 
such projections.     
The third alternative suggests that chemical-induced hyperpolarization of PVH cell 
bodies is overwhelmed by increased neurotransmitter release at PVH synaptic junctions.  
Frequency and current intensity affect the rate of neuronal discharge and the population 
of activated neurons, respectively.  Thus, with increasing frequency and current intensity, 
more neurons are recruited and discharge at a faster rate.  At synaptic junctions within 
the PVH, this leads to a greater release of neurotransmitter and frequency of excitatory 
post-synaptic potentials arriving at the cell body.  As a result, hyperpolarization due to 
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muscimol-induced chloride influx may be progressively overwhelmed, evoking an action 
potential. 
A final possibility for the lack of complete inhibition is the presence of alternative 
pathways mediating a portion of the sympathetic and pressor responses to OVLT 
stimulation.  Early studies conducted by Enoch and Kerr in anesthetized cats utilized a 
combination of electrical stimulation and brain sectioning to describe two distinct 
vasopressor pathways within the hypothalamus 82, 83.  The lateral pathway, arising from 
the suprachiasmatic nucleus and medial forebrain bundle, passes through the lateral and 
ventromedial (VMH/ME) hypothalami to terminate in the lateral mesencephalic 
tegmentum.  The periventricular pathway begins in the posterior hypothalamic area and 
connects to the periaqueductal grey region.  Follow-up studies performed in anesthetized 
rats have demonstrated a link between these hypothalamic pathways and activation of 
the lamina terminalis.  Fink and colleagues observed that electrolytic lesion of the 
VMH/ME attenuates hemodynamic changes to electrical stimulation of the AV3V 84.  
Similarly, ablation of the periaqueductal grey blunted hemodynamic responses to AV3V 
electrical stimulation 85.  Moreover, Johnson et al. showed that destruction of the 
VMH/ME prevents the onset of Grollman renal wrap hypertension 86.  Altogether, these 
reports indicate alternative pathways, which may contribute to sympathetic and pressor 
responses to electrical stimulation of the OVLT and thus account for the reduction of PVH 
muscimol inhibition with increasing magnitude of OVLT electrical stimulation. 
In summary, the lamina terminalis is a forebrain region influential in 
sympathetically-mediated changes in blood pressure.  Activation of its individual nuclei 
evokes unique hemodynamic responses in end-organ vasculature.  The present study 
contributes two major findings to the understanding of lamina terminalis function: 1) 
activation of the OVLT increases sympathetic outflow to the renal nerve and ABP and 2) 
the full expression of these responses is dependent upon synaptic signaling at the PVH.  
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These results are consistent with previous studies, which show acute increases in 
sympathetic outflow and blood pressure to hypertonic and ANGII stimulation of the lamina 
terminalis 13, 69.  However, the sensation of circulating factors, mono- and polysynaptic 
pathways, and neurotransmitters involved in signaling from the lamina terminalis require 
further investigation.  Insight into these underlying mechanisms will contribute to a greater 
understanding of how sympathetic outflow to the vasculature is regulated.  From this, a 
possible role for the lamina terminalis in the etiology of hypertension may be more 
thoroughly described.   
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CHAPTER SIX 
PERSPECTIVES AND FUTURE IMPLICATIONS 
The affect of dietary sodium upon blood pressure has been a source of clinical 
and basic investigation in recent years.  The results of the DASH (Dietary Approaches to 
Stop Hypertension) clinical trial showed that a reduction in sodium chloride intake 
effectively reduces blood pressure in both hypertensive and non-hypertensive individuals 
87.  Furthermore, high dietary sodium chloride increases the activity of the sympathetic 
nervous system to produce chronic blood pressure elevation in human and experimental 
forms of salt-sensitive hypertension 63, 88.  However, several questions that remain are: 
where/how is plasma sodium chloride sensed by the CNS and what are the CNS cellular 
mechanisms underlying salt-sensitive hypertension  
Studies have shown that the lamina terminalis, a region of interconnected nuclei 
along the anterior wall of the third ventricle, possesses sensitivity to changes in plasma 
sodium chloride concentration 89.  Acute stimulation of these structures with hypertonic 
saline increases LSNA, RSNA and ABP in vivo and in vitro 31, 57.  Chemical inhibition or 
ablation of the OVLT significantly decreases LSNA and RSNA, but not ABP, to 
intracarotid infusion of hypertonic saline 69.  In the context of salt-sensitive hypertension, 
intracarotid, but not intravenous, infusion of hypotonic saline decreased ABP in DOCA 
salt-sensitive rats.  Furthermore, this model of hypertension is supported by increased 
sympathetic outflow due to elevated plasma sodium chloride concentration 64, 90.  
Altogether, these data implicate the lamina terminalis as a major center for 
osmosensitivity, with influence over sympathetic outflow and ABP.   
One mechanism within the lamina terminalis implicated in its osmosensitivity is the 
TRPV1 receptor.  Depolarization to osmotic stimulation was not observed in OVLT cells 
from TRPV1 knockout mice and these responses in wild type neurons could be blocked 
with a TRPV antagonist 20.  Moreover, intracarotid infusion of aTRPV1 agonist evoked 
 40
increases in ABP in anesthetized rats 91.  A remaining question is whether these 
receptors mediate chronically elevated sympathetic outflow and ABP in hypertension.  
One set of experiments that could address this question involves selective inhibition of 
the TRPV1 receptor in DOCA-salt rats.  A reduction in sympathetic outflow and ABP 
following TRPV1 inhibition would suggest that these receptors mediate a portion of the 
salt-sensitive hypertension.    
Downstream of the lamina terminalis, anatomical studies have identified the PVH 
as a prominent efferent target 21, 22.  Renal cortical microinjections of pseudorabies virus 
revealed positive cell bodies within the PVH prior to lamina terminalis infection 5.  
Functionally, blockade of PVH AT1 receptors attenuated RSNA and pressor responses to 
intracarotid infusion of hypertonic saline 31.  Similarly, antagonism of PVH glutamate 
receptors blunted LSNA responses to introduction of hypertonic saline in an in situ rat 
preparation 57.  One remaining question is whether these receptors support the elevated 
sympathetic outflow observed in salt-sensitive hypertension.  To address this question, 
microinjections of either losartan (selective AT1 antagonist) or kynurenic acid (non-
selective ionotropic excitatory amino acid antagonist) could be made into the PVH of 
DOCA-salt rats.  Subsequent decreases in SNA and ABP would suggest a role for these 
receptors in salt-sensitive hypertension.     
Recently, a compelling argument made by Osborn et al. 13 suggested that 
increased plasma sodium chloride alone might not be sufficient to generate neurogenic 
hypertension.  Instead, chronic elevations in SNA and ABP may be the result of a 
synergistic interaction between sodium chloride and ANGII upon circumventricular organs 
13.  As primary evidence for this hypothesis, elevated plasma norepinephrine 
concentrations were observed following infusion of ANGII in rats on a high, but not 
normal, sodium chloride diet 92.  Moreover, a high salt diet increased TPR and ABP in 
conscious dogs receiving chronic subpressor infusions of ANGII, while animals on a 
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normal salt diet were unaffected 93.  Though the cellular mechanisms subserving this 
hypothesized interaction remain unclear, stretch-inactivated cation (SIC) channels and 
TRPV1 receptors have been proposed to play a role 13, 94.  
Elevated dietary sodium chloride upregulates the sympathetic nervous system to 
support chronically elevated blood pressure 63, 88.  The circumventricular organs of the 
lamina terminalis are an osmosensitive site, where elevated plasma osmolality may 
influence long-term changes in sympathetic outflow and ABP.  However, the cellular 
mechanisms mediating osmosensitivity within these nuclei remain unclear, though current 
findings suggest the involvement of TRPV1 and/or SIC channels.  Furthermore, sodium 
chloride and ANGII may act in concert upon these cellular targets to affect long-term 
changes in blood pressure and sympathetic nerve activity.  Future experiments are 
needed to investigate these mechanisms along with the downstream receptors and 
substrates in support of osmotically-induced synaptic signaling in salt-sensitive 
hypertension.  From this work, a greater comprehension of the etiology of salt-sensitive 
hypertension and possible anti-hypertensive therapies will be gained.           
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